cephalosporin c has been researched along with Bowel Diseases, Inflammatory in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bishu, S; Chiu, GF; El-Zaatari, M; Grasberger, H; Kao, JY; Lin, KD; Owyang, SY; Waljee, AK; Wu, DC; Zhang, M | 1 |
| Higuchi, K; Houchi, H; Ikawa, K; Ikeda, K; Morikawa, N; Ohge, H; Sueda, T | 1 |
| Borgundvaag, B; Croitoru, K; Gnanasuntharam, P; Le, B; Leung, W; Malhi, G; McGeer, AJ; Nguyen, GC; Silverberg, MS; Steinhart, AH; Thanabalan, R; Weizman, AV; Willey, BM | 1 |
| Balasubramanian, S; Giannadaki, E; Greenstein, AJ; Manousos, ON; Mouzas, IA; Sachar, DB | 1 |
4 other study(ies) available for cephalosporin c and Bowel Diseases, Inflammatory
| Article | Year |
|---|---|
Effects of Anti-Helicobacter pylori Therapy on Incidence of Autoimmune Diseases, Including Inflammatory Bowel Diseases.
Topics: Adult; Aged; Anti-Bacterial Agents; Arthritis, Rheumatoid; Autoimmune Diseases; Case-Control Studies; Cephalosporins; Colitis, Ulcerative; Crohn Disease; Dermatomyositis; Female; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Inflammatory Bowel Diseases; Lupus Erythematosus, Systemic; Male; Middle Aged; Mortality; Pemphigus; Peptic Ulcer; Polymyositis; Proportional Hazards Models; Scleroderma, Systemic; Sjogren's Syndrome; Taiwan; Urinary Tract Infections; Vasculitis | 2019 |
Peritoneal pharmacokinetics of cefepime in laparotomy patients with inflammatory bowel disease, and dosage considerations for surgical intra-abdominal infections based on pharmacodynamic assessment.
Topics: Abdomen; Adult; Aged; Anti-Bacterial Agents; Ascitic Fluid; Bacteria, Aerobic; Cefepime; Cephalosporins; Female; Humans; Inflammatory Bowel Diseases; Male; Microbial Sensitivity Tests; Monte Carlo Method; Peritonitis | 2008 |
Prevalence and predictors of MRSA, ESBL, and VRE colonization in the ambulatory IBD population.
Topics: Adult; Aged; Ambulatory Care; Anti-Bacterial Agents; beta-Lactamases; Carrier State; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Enterococcus; Female; Histamine H2 Antagonists; Hospitalization; Humans; Inflammatory Bowel Diseases; Logistic Models; Male; Methicillin-Resistant Staphylococcus aureus; Metronidazole; Middle Aged; Nose; Prevalence; Proton Pump Inhibitors; Rectum; Risk Factors; Staphylococcal Infections; Vancomycin; Vancomycin Resistance; Young Adult | 2012 |
Management of varicella infection during the course of inflammatory bowel disease.
Topics: Acyclovir; Adult; Anti-Inflammatory Agents; Antiviral Agents; Azathioprine; Cause of Death; Cephalexin; Cephalosporins; Chickenpox; Child; Colectomy; Colitis, Ulcerative; Crohn Disease; Female; Glucocorticoids; Humans; Immunocompromised Host; Immunosuppressive Agents; Inflammatory Bowel Diseases; Injections, Intravenous; Male; Megacolon, Toxic; Methylprednisolone; Prednisone; Rectum; Remission Induction; Treatment Outcome | 1997 |